FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Methotrexate Sodium Tablet
Status: Resolved
»Duration of Shortage: 07/21/2023 - 06/27/2024
»Therapeutic Categories: Rheumatology; Dermatology; Dental; Oncology

Expand all

Accord Healthcare Inc. (Revised 06/27/2024)

Company Contact Information:
866-941-7875, option 2

Presentation

Tablet, 2.5 mg (NDC 16729-486-01)

Note:

Available

Amneal Pharmaceuticals (Revised 06/27/2024)

Company Contact Information:
866-525-7270

Presentation

Tablet, 2.5 mg (NDC 69238-1423-6)
Tablet, 2.5 mg (NDC 69238-1423-1)

Note:

Available

Eugia US LLC (Revised 06/27/2024)

Company Contact Information:
888-238-7880

Presentation

Tablet, 2.5 mg (NDC 59651-182-01)

Note:

Available

Hikma Pharmaceuticals USA, Inc. (Revised 06/27/2024)

Company Contact Information:
800-631-2174

Presentation

Tablet, 2.5 mg (NDC 0054-4550-25)

Note:

Available

Mylan Pharmaceuticals Inc., a Viatris Company (Revised 06/27/2024)

Company Contact Information:
800-796-9526

Presentation

Tablet, 2.5 mg (NDC 0378-0014-01)

Note:

Available

Sun Pharmaceutical Industries, Inc. (Revised 06/27/2024)

Company Contact Information:
800-818-4555

Presentation

Methotrexate Sodium, Tablet, 2.5 mg (NDC 47335-235-83)
Methotrexate Sodium, Tablet, 2.5 mg (NDC 47335-235-96)

Note:

Available

Teva Pharmaceuticals USA, Inc. (Revised 06/27/2024)

Company Contact Information:
800-545-8800

Presentation

Tablet, 2.5 mg (NDC 0555-0572-02)
Tablet, 2.5 mg (NDC 0555-0572-35)
Trexall, Tablet, 5 mg (NDC 51285-366-01)
Trexall, Tablet, 7.5 mg (NDC 51285-367-01)
Trexall, Tablet, 10 mg (NDC 51285-368-01)
Trexall, Tablet, 15 mg (NDC 51285-369-01)

Note:

Available

Zydus Pharmaceuticals USA Inc. (Revised 06/27/2024)

Company Contact Information:
877-993-8779

Presentation

Tablet, 2.5 mg (NDC 68382-775-01)

Note:

Available